Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Collegium Pharmaceutical Inc.
Headquarters: Stoughton , MA, United States of America
Website: http://www.collegiumpharma.com...
Year Founded: 2003
Status: Public
Industry Sector: HealthTechnology
CEO: Vikram Karnani, MBA
Number Of Employees: 357
Enterprise Value: $1,950,300,757
PE Ratio: 16
Exchange/Ticker 1: NASDAQ:COLL
Exchange/Ticker 2: N/A
Latest Market Cap: $930,711,424
BioCentury | Mar 19, 2025
Management Tracks
CFO Brian Stephenson exits Bridgebio
Plus: CEO Edward Kayne steps down at Stoke, and updates from Collegium, Pyxis, Recursion and Tonix
BioCentury | Feb 28, 2025
Management Tracks
Indivior CEO exits as activist shareholder Oaktree presses for change
Plus: Paul Hitchin succeeds Laetitia Rouxel as CFO of Evotec, and updates from Elekta, Forx, Abzena and more
BioCentury | Jul 29, 2024
Deals
Deals Report: GSK is latest pharma to draw on Flagship portfolio
Plus: Day One’s ex-U.S. deal with Ipsen; Novartis taps Dren Bio’s oncology platform; BI buys Avalon-backed Nerio; and Collegium’s ADHD takeout
BioCentury | Apr 4, 2024
Management Tracks
Upstream names new CEO, CFO and COO
Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
BioCentury | Jan 4, 2023
Management Tracks
Ex-Checkmate CEO Bash to lead ZielBio
Plus: Allogene’s Amado joins Zai Lab, and updates from bluebird bio, Rejuvenate, Novadip and more
BioCentury | May 11, 2022
Management Tracks
Shea replacing Kim as CEO of Inovio
Plus new chief commercial officer at DNA Script, and updates from Boston Pharma, Quantum SI, Beta, Longeveron and more
BioCentury | Feb 15, 2022
Deals
Feb. 14 Quick Takes: Collegium adds analgesic via BioDelivery buyout
Plus Roivant starts new subsidiary and updates from CStone, Astellas and Seagen
BioCentury | Jun 29, 2021
Management Tracks
Heaton to join Janssen as global head for vaccines; plus AstraZeneca promotes Galbraith, Ribometrix, Shoreline, Ribon and more
Penny Heaton said via a social media post that she will be stepping down as the CEO from Bill & Melinda Gates Medical Research Institute, to join the Janssen Pharmaceutical unit of Johnson &
BioCentury | Jun 11, 2019
Company News
Management Tracks: Agios’ Biller to retire as CSO; plus Vectura, Molecular Partners, F-star and more
BioCentury | Apr 4, 2019
Company News
Management tracks: Gottlieb's next move, plus Vertex, Centogene and more
Items per page:
1 - 10 of 84